A novel autophagy-related long non-coding RNAs signature predicting progression-free interval and I-131 therapy benefits in papillary thyroid carcinoma.

Open Med (Wars) · 2023 · PMC9985460 · PMID 36880066

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

As expected, I-131 therapy was associated with poor PFI in patients from the unfavorable group ( P = 0.23; Figure 9b ) while being associated with improved PFI in patients from the favorable group ( P = 0.057; Figure 9c ) although the associations did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.